Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
osu1144958112.pdf (7.07 MB)
ETD Abstract Container
Abstract Header
Suramin as a chemo- and radio-sensitizer: preclinical translational studies
Author Info
Xin, Yan
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=osu1144958112
Abstract Details
Year and Degree
2006, Doctor of Philosophy, Ohio State University, Pharmacy.
Abstract
Previous studies in our laboratory showed that low-dose suramin, an inhibitor of fibroblast growth factor action, enhances sensitivity of various human tumors in preclinical and clinical studies to chemotherapy. Chemosensitization required apoptosis, and increased the extent and duration of the induction of apoptosis. The primary focus of this dissertation research was to explore, in preclinical studies, therapeutic approaches for therapy enhancement based on this mechanism. A phase III clinical trial in superficial bladder cancer, which emanated from our laboratory, showed that optimizing mitomycin C delivery nearly doubled the recurrence-free survival of treated patients to 40%. Tumor sensitization with suramin might yield further therapeutic improvements, and was investigated in in vitro and in vivo studies. Studies in Chapter 2 demonstrated enhanced antitumor activity of mitomycin C, administered at subtherapeutic and therapeutic regimens. Various preclinical and clinical studies determined that suramin sensitized tumor tissue at low but not at high concentrations, presumably due to additional pharmacologic effects at elevated concentrations. Studies to overcome this limitation, especially in tumors containing high fibroblast growth factor concentrations, used pentosan polysulfate, another nonspecific FGF inhibitor. This agent was also a chemosensitizer, but combined use with suramin did not increase the overall efficacy (Chapter 3). Radiotherapy depends on induction of apoptosis for its anticancer effect, as is the case for many forms of chemotherapy, and led to our evaluation of suramin as radiosensitizer. Results in Chapter 4 and Chapter 5 showed that low-dose suramin sensitized the radiation response of both radiosensitive (prostate PC-3) and relatively radioresistant (pharynx FaDu, pancreatic Hs 766T) xenograft tumors, thereby further extending the clinical application of suramin to modulate radiotherapy. More importantly, the radiosensitizaiton effect of suramin had tumor type specific dose dependence, with a narrow sensitiziting window in FaDu and a wider range in Hs 766T (pancreatic) xenograft tumors (Chapter 5), suggesting the necessity of drug target-specified dosing regimen for suramin. To better understand the biphasic effect of suramin in combination with radiation, pharamacodynamic studies at a microscopic level were conducted (Chapter 6). The results indicated that low-dose but not high-dose suramin enhanced radiation-induced apoptosis, inhibiting radiation-induced upregulation of phospho-ERK and survivin, two survival signals involved in radioresistance.
Committee
M. Guillaume Wientjes (Advisor)
Pages
193 p.
Keywords
suramin
;
chemosensitizer
;
radiosensitizer
;
mitomycin C
;
survivin
;
paclitaxel
;
bladder cancer
;
pancreatic cancer
;
prostate cancer
;
head and neck cancer
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Xin, Y. (2006).
Suramin as a chemo- and radio-sensitizer: preclinical translational studies
[Doctoral dissertation, Ohio State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=osu1144958112
APA Style (7th edition)
Xin, Yan.
Suramin as a chemo- and radio-sensitizer: preclinical translational studies.
2006. Ohio State University, Doctoral dissertation.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=osu1144958112.
MLA Style (8th edition)
Xin, Yan. "Suramin as a chemo- and radio-sensitizer: preclinical translational studies." Doctoral dissertation, Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc_num=osu1144958112
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
osu1144958112
Download Count:
1,244
Copyright Info
© 2006, all rights reserved.
This open access ETD is published by The Ohio State University and OhioLINK.